Table 3.
Indication
|
Outcome
|
|
Estimate
|
Ref.
|
Adenoma or AAC | Complete excision (R0) | 96.4% | [38] | |
Adenoma or AAC | Recurrence | 9.4% | [38] | |
Adenoma or AAC | Complications | 28.3% | [38] | |
Adenoma or AAC | Mortality1 | 0.9% | [6,12,14,20,22,24,25,28,30,32,39,41,43,45,47-52,58,62,64,67,72,74,76-79] | |
AAC | Survival at 5 yr | T1 | 40% | [50] |
T1 + T2 | 64.3% | [41] | ||
T2 | 16% | [50] | ||
T3 | 0% | [50] | ||
T3 + T4 | 18.2% | [41] |
Pooled mortality of cited studies (5 deaths in 532 surgical ampullectomies across 30 studies).
AAC: Ampullary adenocarcinoma.